文献速递脊柱脊髓外科

脊柱特发性肥厚性硬脑膜炎:诊断特征、临床管理与手术结局的系统综述

Spinal Idiopathic Hypertrophic Pachymeningitis: A Systematic Review of Diagnostic Features, Clinical Management, and Surgical Outcomes.
PubMed 文献 · World Neurosurg · 2025-04-25

本系统综述纳入29项研究共43例成人脊柱特发性肥厚性硬脑膜炎患者,总结诊断特征、治疗与手术结局。中位诊断年龄54岁,女性略多(53.5%);常见症状为下肢无力(51.2%)、感觉异常(48.8%)和背痛(46.5%);MRI为主要诊断工具(86%);复发率27.6%,中位复发时间5个月。

要点

  • MRI是脊柱特发性肥厚性硬脑膜炎的主要诊断工具,占86%的病例。
  • 激素治疗是主要内科管理手段,常需手术减压。
  • 复发率27.6%,中位复发时间5个月。

核心结论

  • 脊柱特发性肥厚性硬脑膜炎在诊断和管理上具有独特性,常需更积极的初始管理,因脊髓压迫可能导致不可逆神经损伤。
  • 对于进行性脊髓病症状且无肿瘤征象的患者,鉴别诊断中应考虑脊柱特发性肥厚性硬脑膜炎。

研究设计与样本

  • 系统综述,检索PubMed、EMBASE、Web of Science和Cochrane数据库,从建库至2024年10月31日。
  • 纳入29项研究(8项病例系列和21项病例报告),共43例成人脊柱特发性肥厚性硬脑膜炎患者。

主要发现

  • 中位诊断年龄54岁,女性略多(53.5%)。
  • 常见症状包括下肢无力(51.2%)、感觉异常(48.8%)和背痛(46.5%)。
  • MRI为主要诊断工具(86%的病例)。
  • 组织病理学常见炎性浸润(74.4%)和纤维化(59%)。
  • 复发率27.6%,中位复发时间5个月。

临床怎么用

  • 激素治疗是主要的内科管理手段,手术减压常有必要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To comprehensively review the diagnostic features, clinical management, and surgical outcomes of spinal idiopathic hypertrophic pachymeningitis (sIHP) through a systematic analysis of existing literature. METHODS: A systematic review was conducted using PubMed, EMBASE, Web of Science, and Cochrane databases from inception to October 31, 2024. Studies reporting on adult patients with sIHP, including clinical, treatment, outcome, and follow-up data, were included. Data extraction covered patient demographics, clinical presentation, diagnostic workup, management strategies, and outcomes. RESULTS: The review included 29 studies, comprising 8 case series and 21 case reports, with a total of 43 patients. The median age at diagnosis was 54 years, with a slight female predominance (53.5%). Common presenting symptoms included lower extremity weakness (51.2%), sensory complaints (48.8%), and back pain (46.5%). Magnetic resonance imaging was the primary diagnostic tool (86% of cases). Histopathological findings typically showed inflammatory infiltrate (74.4%) and fibrosis (59%). Steroid therapy was the primary medical management, with surgical decompression often necessary. The recurrence rate was 27.6%, with a median time to recurrence of 5 months. CONCLUSIONS: sIHP presents unique diagnostic and management challenges compared to its cranial counterpart. While sharing similarities in demographic patterns and diagnostic approaches, sIHP often requires more aggressive initial management due to the risk of irreversible neurological damage from spinal cord compression. The findings underscore the need to consider sIHP in the differential for patients with progressive myelopathic symptoms without signs of neoplasm.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Balasubramanian K, Kharbat AF, Call-Orellana F, et al. Spinal Idiopathic Hypertrophic Pachymeningitis: A Systematic Review of Diagnostic Features, Clinical Management, and Surgical Outcomes. World Neurosurg. 2025. PMID: 40288528. doi:10.1016/j.wneu.2025.124008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。